Muscle strength but not functional capacity is associated with plasma interleukin-6 levels of community-dwelling elderly women

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 12, 2008, Pages 1148-1153

  Oliveira, D M G ^a   Narciso, F M S ^a   Santos, M L A S ^a   Pereira, D S ^a   Coelho, F M ^a   Dias, J M D ^a   Pereira, Leani S M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Aging; Elderly women; IL 6; Interleukin 6; Muscle strength; Sarcopenia

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; MONOCLONAL ANTIBODY;

AGED; AGING; ARTICLE; BRAZIL; CHRONIC DISEASE; COMMUNITY CARE; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; DYNAMOMETER; ELDERLY CARE; FEMALE; FUNCTIONAL STATUS; GAIT; HUMAN; IMMUNOREGULATION; KNEE FUNCTION; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MENTAL STRESS; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; OBSERVATIONAL STUDY; POST HOC ANALYSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SOCIAL STRESS;

EID: 62749193567     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008001200017     Document Type: Article

References (40)

1. Gontijo B. Envelhecimento global: trinfo e desafio. In: Anonimous, Envelhecimento ativo: uma política de saúde. Brasília: Organização Pan-Americana de Saúde; 2005. p 8-12.
2. Jette AM. Assessing disability in studies on physical activity. Am J Prev Med 2003; 25: 122-128.
3. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004; 59A: 255-263.
4. Frontera WR, Bigard X. The benefits of strength training in the elderly. Sci Sports 2002; 17: 109-116.
5. Doherty TJ. Invited review: aging and sarcopenia. J Appl Physiol 2003; 95: 1717-1727.
6. Macaluso A, De Vito G. Muscle strength, power and adaptations to resistance training in older people. Eur J Appl Physiol 2004; 91: 450-472.
7. Reeves ND, Narici MV, Maganaris CN. Myotendinous plasticity to ageing and resistance exercise in humans. Exp Physiol 2006; 91: 483-498.
8. Skelton DA, Greig CA, Davies JM, Young A. Strength, power and related functional ability of healthy people aged 65-89 years. Age Ageing 1994; 23: 371-377.
9. Pereira LS, Narciso FM, Oliveira DM, Coelho FM, Souza DD, Dias RC. Correlation between manual muscle strength and interleukin-6 (IL-6) plasma levels in elderly community-dwelling women. Arch Gerontol Geriatr 2008 (in press).
10. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti M-C, Cohen HJ, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999; 47: 639-646.
11. Krabbe KS, Perdersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39: 687-699.
12. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 1993; 41: 176-181.
13. Ferrucci L, Pennix BWJH, Volpato S, Harris TB, Banden-Roche K, Balfour J, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 2002; 50: 1947-1954.
14. Cappola AR, Xué QL, Ferrucci L, Guralnik JM, Volpato S, Fried LP. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 2003; 88: 2019-2025.
15. Roubenoff R, Parise H, Payette HA, Abad LW, D'Agostino R, Jacques PF, et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: The Framingham Heart Study. Am J Med 2003; 115: 429-435.
16. Pennix BWJH, Kritchevsky SB, Newman AB, Nicklas BJ, Simonsick EM, Rubin S, et al. Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc 2004; 52: 1105-1113.
17. Barbieri M, Ferrucci LR, Ragno E, Corsi A, Bandinelli S, Bonafè M, et al. Chronic inflammation and the effect of IGFI on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 2003; 284: E481-E487.
18. Schaap LA, Pluijm SMF, Deeg DJH, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 2006; 119: 526e9-526e17.
19. Haddad F, Zaldivar F, Cooper DM, Adanis GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol 2005; 98: 911-917.
20. United Nations. Problems of the elderly and the aged. Draft programme and arrangements for the World Assembly on the elderly: Report of the Secretary General. New York: United Nations; 1980.
21. World Health Organization Physical Status. The use and interpretation of antropometry. Geneve: WHO; 1995.
22. Bertolucci M. O mini-exame do estado mental em uma população geral. Arq Neuropsiquiatr 1994; 52: 1-7.
23. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982; 17: 37-49.
24. Cohen J. Statistical power analysis for the behavioral sciences. 2nd edn. New York: Psychology Press Publication; 1988.
25. Bean JF, Kiely DK, Herman S, Leveille SG, Mizer K, Frontera WR. The relationship between leg power and physical performance in mobility-limited older people. J Am Geriatr Soc 2002; 50: 461-467.
26. VanSwearingen JM, Brach JS. Making geriatric assessment work: selecting useful measures. Phys Ther 2001; 81: 1233-1252.
27. Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 2007; 102: 919-925.
28. Luz C, Dornelles F, Preissler T, Collaziol D, da Cruz IM, Bauer ME. Impact of psychological and endocrine factors on cytokine production of healthy elderly people. Mech Ageing Dev 2003; 124: 887-895.
29. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A 2003; 100: 9090-9095.
30. Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA. Cynical hostility, depressive symptoms, and the expression of inflammatory risk markers for coronary heart disease. J Behav Med 2003; 26: 501-515.
31. Sjogren E, Leanderson P, Kristenson M, Ernerudh J. Interleukin-6 levels in relation to psychosocial factors: studies on serum, saliva, and in vitro production by blood mononuclear cells. Brain Behav Immun 2006; 20: 270-278.
32. Pedersen BK, Steensberg A, Schjerling P. Muscle-derived interleukin-6: possible biological effects. J Physiol 2001; 536: 329-337.
33. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 2002; 16: 1335-1347.
34. Reuben DB, Judd-Hamilton L, Harris TB, Seeman TE. The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur studies of successful aging. J Am Geriatr Soc 2003; 51: 1125-1130.
35. Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, et al. Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil 2003; 24: 113-119.
36. Steinacker JM, Lormes W, Reissnecker S, Liu Y. New aspects of the hormone and cytokine response to training. Eur J Appl Physiol 2004; 91: 382-391.
37. Kohut ML, McCann DA, Russell DW, Konopka DN, Cunnick JE, Franke WD, et al. Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults. Brain Behav Immun 2006; 20: 201-209.
38. Fischer CP, Bernsten A, Perstrup B, Eskildsen P, Pedersen BK. Plama levels of interleukin-6 and C-reative protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sports 2007; 17: 580-587.
39. Portegijs E, Rantanen T, Sipila S, Laukkanen P, Heikkinen E. Physical activity compensates for increased mortality risk among older people with poor muscle strength. Scand J Med Sci Sports 2007; 17: 473-479.
40. Petersen AMW, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98: 1154-1162.